Dawn of the DNA Drug? | GenomeWeb

Dawn of the DNA Drug?

The University of Pennsylvania's Matthew Morrow and David Weiner write in Scientific American that DNA-based drugs and vaccines may finally get their time in the spotlight.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Zika Beware

This Week in PLOS

This Week in Cell

Biotech Court

Such High Hopes

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.